Allergy Therapeutics, a specialty pharmaceutical company, announced the appointment of Nick Wykeman to the board as finance director.
Mr. Wykeman was most recently at Skyepharma PLC until August 2015 where he was the Group Financial Controller for six years.

Prior to that, he had also worked at Quest International (a part of ICI PLC) as the Group Financial Controller (Special Projects), following six years at Deloitte & Touche.

Mr. Wykeman has a BSc (Hons) in Economics and is a qualified accountant, being a member of the Institute of Chartered Accountants of England and Wales. ■

• NewVoiceMedia appoints president and COO to strengthen U.S. presence
• Zotefoams appoints Doug Robertson as non-executive director
• Rotork to appoint Peter Dilnot as non-executive director
• Stephen Bentley to join Frenkel Topping Group as CFO
• 1Spatial appoints Francis Small as director

---

More inside POST